PANC — Panacos Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$8.68m
- $0.18m
Annual balance sheet for Panacos Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2003 December 27th | R2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.26 | 4.88 | 87.1 | 60.8 | 51.9 |
| Net Total Receivables | 4.18 | 0.28 | 0.389 | 0.066 | 0.147 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.24 | 5.22 | 88.6 | 63 | 53.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.5 | 0.31 | 2.35 | 2.12 | 1.04 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 17.7 | 6.33 | 91.6 | 65.7 | 55.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.88 | 2.74 | 5.82 | 6.51 | 7.34 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.41 | 2.86 | 5.97 | 6.97 | 26.8 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 12.2 | 3.47 | 85.6 | 58.7 | 28.9 |
| Total Liabilities & Shareholders' Equity | 17.7 | 6.33 | 91.6 | 65.7 | 55.7 |
| Total Common Shares Outstanding |